RTK-10043-88636 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-05
Dose 1 — Janssen/Johnson & Johnson
2021-04-08
Registered in v-safe
2021-04-08
Survey response — days 1–6 daily, dose 1
MedDRA: Decreased appetite — Feeling: Good · Site: Pain, Redness · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: loss of appetite

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-08
Report sent to call center — days 1–6 daily, dose 1
Be unable to work · Be unable to do your normal daily activities

no matching call case

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-05	Janssen/Johnson & Johnson

Call center

1 check-in flagged for a call with no call center case on record

See the call center timeline

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-08

Systemic reaction (other): loss of appetite

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Decreased appetite	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release